AROMICS is a biotech company committed to the discovery and development of novel drugs and diagnostic methods to target relevant human diseases and improve patient’s quality of life.

We believe that OMIC technologies represent an important first step towards gaining biological insights into:

  • How drugs work, giving them added value, reducing attrition rates and advancing  through the clinic.
  • Determining clinically predictive molecular endpoints that help physicians manage the disease, drive prescriptions and monitor drug response.


06/03/2020 | Aromics advances at E-Forum Health 2020
Dr. Carme Plasencia, CEO of Aromics, will present the advances on Bermes Project... More

06/09/2020 | E-pitch Healthcare Forum
Aromics selected among the eight companies participating in the E-pitch Investor... More


04/01/2020 | COVID information
In the context of the current global health crisis caused by COVID-19, Aromics... More

03/10/2020 | Asbestos, a health problem. How can we get it out of the buildings?
The Association of Technical Architects and Building Engineers of Barcelona... More